PedvaxHIB 7.5 ug/.5mL
Haemophilus b Conjugate Vaccine (Meningococcal Protein Conjugate) · INJECTION, SUSPENSION · Merck Sharp & Dohme LLC
PedvaxHIB is a injection, suspension containing haemophilus b conjugate vaccine (meningococcal protein conjugate) at 7.5 ug/.5mL, taken intramuscular. Manufactured by Merck Sharp & Dohme LLC.
Key Facts
- Brand Name
- PedvaxHIB
- Generic Name
- Haemophilus b Conjugate Vaccine (Meningococcal Protein Conjugate)
- NDC Code (Product)
0006-4897- Manufacturer
- Merck Sharp & Dohme LLC
- Strength
- 7.5 ug/.5mL
- Dosage Form
- INJECTION, SUSPENSION
- Route
- INTRAMUSCULAR
- Marketing Status
- Application #
- BLA103237
- Marketing Start
- 12/20/1989
Recall History
No Recall HistoryFrequently Asked Questions
What is PedvaxHIB used for?
PedvaxHIB contains Haemophilus b Conjugate Vaccine (Meningococcal Protein Conjugate). It is a injection, suspension taken intramuscular. Consult your doctor for specific uses.
Is PedvaxHIB a controlled substance?
PedvaxHIB is not classified as a controlled substance by the DEA.
What is the generic name for PedvaxHIB?
The generic name for PedvaxHIB is Haemophilus b Conjugate Vaccine (Meningococcal Protein Conjugate). There are no other listed brand versions of Haemophilus b Conjugate Vaccine (Meningococcal Protein Conjugate).
What is the NDC code for PedvaxHIB 7.5 ug/.5mL?
The NDC (National Drug Code) for PedvaxHIB 7.5 ug/.5mL is 0006-4897, listed by Merck Sharp & Dohme LLC.
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)